Synthesis and β-Glucuronidase Inhibitory Potential of Benzimidazole Derivatives

Author(s): Khalid Mohammed Khan, Momin Khan, Nida Ambreen, Fazal Rahim, Shagufta Naureen, Shahnaz Perveen, M. Iqbal Choudhary, Wolfgang Voelter.

Journal Name: Medicinal Chemistry

Volume 8 , Issue 3 , 2012

Become EABM
Become Reviewer

Abstract:

Benzimidazole derivatives 1-24 have been synthesized and their in vitro β-glucuronidase inhibitory activitiy was evaluated. Compounds 15 (IC50 = 6.33 ± 0.40 µM), 7 (IC50 = 22.0 ± 0.33 µM), 2 (IC50 = 23.1 ± 1.78 µM), 17 (IC50 = 23.9 ± 1.46 µM), and 3 (IC50 = 33.8 ± 1.61 µM) showed more potent β-glucuronidase inhibitory activity than the standard (D-saccharic acid 1,4 lactone, IC50 = 48.4 ± 1.25 µM). This study has identified a new series of potential β-glucuronidase inhibitors. A structure-activity relationship has also been studied.

Keywords: Benzimidazole, β-glucuronidase inhibition, glucuronosyl-O-bonds, antihelmintic, anticoagulant, leukaemia, antihistaminic, antihypertensive, dimethylformamide, lepromatous

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 8
ISSUE: 3
Year: 2012
Page: [421 - 427]
Pages: 7
DOI: 10.2174/1573406411208030421
Price: $58

Article Metrics

PDF: 20